Correlation Between Instil Bio and ABVC Biopharma

Can any of the company-specific risk be diversified away by investing in both Instil Bio and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Instil Bio and ABVC Biopharma, you can compare the effects of market volatilities on Instil Bio and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and ABVC Biopharma.

Diversification Opportunities for Instil Bio and ABVC Biopharma

-0.43

Correlation Coefficient

Instil Bio  ABVC Biopharma

Very good diversification

The 3 months correlation between Instil and ABVC is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Instil Bio i.e., Instil Bio and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Instil Bio and ABVC Biopharma

Considering the 90-day investment horizon Instil Bio is expected to generate 6.04 times less return on investment than ABVC Biopharma. In addition to that, Instil Bio is 1.29 times more volatile than ABVC Biopharma. It trades about 0.01 of its total potential returns per unit of risk. ABVC Biopharma is currently generating about 0.09 per unit of volatility. If you would invest  58.00  in ABVC Biopharma on December 27, 2024 and sell it today you would earn a total of  13.00  from holding ABVC Biopharma or generate 22.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Instil Bio  vs.  ABVC Biopharma

Instil Bio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Instil Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Instil Bio is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

ABVC Biopharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Instil Bio and ABVC Biopharma

The main advantage of trading using opposite Instil Bio and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.

The idea behind Instil Bio and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.